The NEMO trial (NRAS melanoma and MEK inhibitor): A rand

  • Rudrapatna, Venkatesh K (PI)

Project: Research project

Project Details

Description

The NEMO trial (NRAS melanoma and MEK inhibitor): A randomized P3 open label multicenter two arm study comparing the efficacy of MEK162 vs Dacarbazine in patients with previously untreated advanced
StatusFinished
Effective start/end date2/28/133/31/16

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.